Novo Nordisk remains confident in the benefit-risk profile of our GLP-1 medicines, when used consistent with their indications and product labeling. Michael Jamison, a spokesperson for Eli Lilly sent a statement: Patient safety is Lillys top priority, and we actively monitor, evaluate, and report safety information for all our medicines
Compounded tirzepatide may be safer than Mounjaro if you take it with your doctor's care
Some people may experience mild digestive upset if they are new to the supplement, but this is usually temporary
Use normal saline (NS) as the preferred solution for IV antibiotics, if possible, to minimize dextrose infusion
The gravity of the situation became even more evident during our pre-surgery discussions
Final Verdict Shed makes GLP-1 treatment both flexible and affordable